Omicron-adapted COVID vaccines may reduce death, hospitalization risk - CIDRAP

Omicron-adapted COVID vaccines may reduce death, hospitalization risk  CIDRAP

UAB circle of Omicron Delta Kappa awarded prestigious honors - The University of Alabama at Birmi...

UAB circle of Omicron Delta Kappa awarded prestigious honors  The University of Alabama at Birmingham

A non-spike nucleocapsid R204P mutation in SARS-CoV-2 Omicron XEC enhances inflammation and patho...

A non-spike nucleocapsid R204P mutation in SARS-CoV-2 Omicron XEC enhances inflammation and pathogenicity  Nature

Southern Miss Omicron Delta Kappa Chapter Reactivated, New Members Inducted - The University of S...

Southern Miss Omicron Delta Kappa Chapter Reactivated, New Members Inducted  The University of Southern Mississippi

Delta and Omicron Variants Partially Evaded COVID-19 Vaccines, Study Indicates - University of Miami

Delta and Omicron Variants Partially Evaded COVID-19 Vaccines, Study Indicates  University of Miami

What do we know about the new Omicron subvariant of COVID, NB.1.8.1? - UChicago Medicine

What do we know about the new Omicron subvariant of COVID, NB.1.8.1?  UChicago Medicine

Long COVID associated with SARS-CoV-2 reinfection among children and adolescents in the omicron e...

Long COVID associated with SARS-CoV-2 reinfection among children and adolescents in the omicron era (RECOVER-EHR): a retrospective cohort study  The Lancet

CDC on Omicron: "We expect it to become the dominant strain in the United States" - C-SPAN

CDC on Omicron: "We expect it to become the dominant strain in the United States"  C-SPAN

New Jersey COVID Update: 1st case of omicron variant detected in NJ - 6abc Philadelphia

New Jersey COVID Update: 1st case of omicron variant detected in NJ  6abc Philadelphia

Long-COVID prevalence may vary by COVID-19 variant, time since infection - CIDRAP

Long-COVID prevalence may vary by COVID-19 variant, time since infection  CIDRAP

Dynamic alterations of oral fungal microbiota in Omicron infected patients - Nature

Dynamic alterations of oral fungal microbiota in Omicron infected patients  Nature

UK’s Omicron Delta Kappa Circle celebrates a century of leadership and legacy - UKNow

UK’s Omicron Delta Kappa Circle celebrates a century of leadership and legacy  UKNow

Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern - World Health Organization ...

Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern  World Health Organization (WHO)

Differential immunity induced by Omicron sublineages in naïve and vaccine breakthrough infections...

Differential immunity induced by Omicron sublineages in naïve and vaccine breakthrough infections  Nature

Enhancing response to Omicron SARS-CoV-2 variant - World Health Organization (WHO)

Enhancing response to Omicron SARS-CoV-2 variant  World Health Organization (WHO)

Tracing the spatial origins and spread of SARS-CoV-2 Omicron lineages in South Africa - Nature

Tracing the spatial origins and spread of SARS-CoV-2 Omicron lineages in South Africa  Nature

Statement on Omicron sublineage BA.2 - World Health Organization (WHO)

Statement on Omicron sublineage BA.2  World Health Organization (WHO)

Determinants of antibody levels and protection against omicron BQ.1/XBB breakthrough infection - ...

Determinants of antibody levels and protection against omicron BQ.1/XBB breakthrough infection  Nature

Multiple infections with Omicron variants increase breadth and potency of Omicron-specific neutra...

Multiple infections with Omicron variants increase breadth and potency of Omicron-specific neutralizing antibodies  Nature

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant - Nature

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant  Nature

Update on Omicron - World Health Organization (WHO)

Update on Omicron  World Health Organization (WHO)

Investigation of a SARS-CoV-2 B.1.1.529 (Omicron) Variant Cluster — Nebraska, November–December 2...

Investigation of a SARS-CoV-2 B.1.1.529 (Omicron) Variant Cluster — Nebraska, November–December 2021 | MMWR  Centers for Disease Control and Prevention | CDC (.gov)

Omicron, Delta, Alpha, and More: What To Know About the Coronavirus Variants - Yale Medicine

Omicron, Delta, Alpha, and More: What To Know About the Coronavirus Variants  Yale Medicine

Where did ‘weird’ Omicron come from? - Science | AAAS

Where did ‘weird’ Omicron come from?  Science | AAAS

SARS-CoV-2 B.1.1.529 (Omicron) Variant — United States, December 1–8, 2021 - Centers for Disease ...

SARS-CoV-2 B.1.1.529 (Omicron) Variant — United States, December 1–8, 2021  Centers for Disease Control and Prevention | CDC (.gov)

Challenges in Inferring Intrinsic Severity of the SARS-CoV-2 Omicron Variant - The New England Jo...

Challenges in Inferring Intrinsic Severity of the SARS-CoV-2 Omicron Variant  The New England Journal of Medicine

Omicron and its Subvariants: A Guide to What We Know - Yale Medicine

Omicron and its Subvariants: A Guide to What We Know  Yale Medicine

A Bivalent Omicron-Containing Booster Vaccine against Covid-19 - The New England Journal of Medicine

A Bivalent Omicron-Containing Booster Vaccine against Covid-19  The New England Journal of Medicine

The latest on COVID-19’s omicron variant: What’s changed? - UT MD Anderson

The latest on COVID-19’s omicron variant: What’s changed?  UT MD Anderson

One year since the emergence of COVID-19 virus variant Omicron - World Health Organization (WHO)

One year since the emergence of COVID-19 virus variant Omicron  World Health Organization (WHO)

Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5 - Nature

Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5  Nature

How severe are Omicron infections? - Nature

How severe are Omicron infections?  Nature

Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections - The New England...

Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections  The New England Journal of Medicine

Paxlovid reduces serious risks from Omicron variants - National Institutes of Health (.gov)

Paxlovid reduces serious risks from Omicron variants  National Institutes of Health (.gov)

Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant - The New England Journal ...

Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant  The New England Journal of Medicine

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination - The New England J...

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination  The New England Journal of Medicine

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection - The New England Journ...

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection  The New England Journal of Medicine

Study: Most People Infected With Omicron Didn’t Know It - Cedars-Sinai

Study: Most People Infected With Omicron Didn’t Know It  Cedars-Sinai

The Omicron Booster: Your Questions Answered - Yale Medicine

The Omicron Booster: Your Questions Answered  Yale Medicine

Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras - The New En...

Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras  The New England Journal of Medicine

Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5 - The New Engla...

Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5  The New England Journal of Medicine

COVID-19’s BA.4 and BA.5 Omicron subvariants: 12 questions, answered - UT MD Anderson

COVID-19’s BA.4 and BA.5 Omicron subvariants: 12 questions, answered  UT MD Anderson

Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | New England Journal o...

Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | New England Journal of Medicine  The New England Journal of Medicine

Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge | New England Journal of M...

Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge | New England Journal of Medicine  The New England Journal of Medicine

Where did Omicron come from? Three key theories - Nature

Where did Omicron come from? Three key theories  Nature

Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1 - The New Engla...

Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1  The New England Journal of Medicine

Protection by a Fourth Dose of BNT162b2 against Omicron in Israel - The New England Journal of Me...

Protection by a Fourth Dose of BNT162b2 against Omicron in Israel  The New England Journal of Medicine

Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa ...

Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa  The New England Journal of Medicine

‘Killer’ immune cells still recognize Omicron variant - Nature

‘Killer’ immune cells still recognize Omicron variant  Nature

Heavily mutated Omicron variant puts scientists on alert - Nature

Heavily mutated Omicron variant puts scientists on alert  Nature

Omicron likely to weaken COVID vaccine protection - Nature

Omicron likely to weaken COVID vaccine protection  Nature

Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa - Nature

Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa  Nature

Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection - The New England...

Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection  The New England Journal of Medicine

An Update on Omicron Subvariants - Johns Hopkins Bloomberg School of Public Health

An Update on Omicron Subvariants  Johns Hopkins Bloomberg School of Public Health

Vaccine-Induced Immune Response to Omicron Wanes Substantially Over Time - National Institutes of...

Vaccine-Induced Immune Response to Omicron Wanes Substantially Over Time  National Institutes of Health (.gov)

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron - The New England Journal of M...

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron  The New England Journal of Medicine

Effectiveness of Bivalent Boosters against Severe Omicron Infection | New England Journal of Medi...

Effectiveness of Bivalent Boosters against Severe Omicron Infection | New England Journal of Medicine  The New England Journal of Medicine

SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex ...

SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex  Science | AAAS

Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron - The New England ...

Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron  The New England Journal of Medicine

TAG-VE statement on Omicron sublineages BQ.1 and XBB - World Health Organization (WHO)

TAG-VE statement on Omicron sublineages BQ.1 and XBB  World Health Organization (WHO)

Omicron: 10 things to know about the very contagious COVID-19 variant - University of California ...

Omicron: 10 things to know about the very contagious COVID-19 variant  University of California - Davis Health

Omicron has caused higher increase in U.S. daily death count than delta variant - PBS

Omicron has caused higher increase in U.S. daily death count than delta variant  PBS

Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2 - Nature

Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2  Nature

COVID-19: Don’t underestimate Omicron, WHO chief warns - UN News

COVID-19: Don’t underestimate Omicron, WHO chief warns  UN News

Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection - The New England Journal...

Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection  The New England Journal of Medicine

Swift and extensive Omicron outbreak in China after sudden exit from ‘zero-COVID’ policy - Nature

Swift and extensive Omicron outbreak in China after sudden exit from ‘zero-COVID’ policy  Nature

Omicron’s lasting mysteries: four questions scientists are racing to answer - Nature

Omicron’s lasting mysteries: four questions scientists are racing to answer  Nature

Plasma Neutralization of the SARS-CoV-2 Omicron Variant - The New England Journal of Medicine

Plasma Neutralization of the SARS-CoV-2 Omicron Variant  The New England Journal of Medicine

BNT162b2 Protection against the Omicron Variant in Children and Adolescents - The New England Jou...

BNT162b2 Protection against the Omicron Variant in Children and Adolescents  The New England Journal of Medicine

Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation - Nature

Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation  Nature

Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron - Nature

Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron  Nature

Omicron is supercharging the COVID vaccine booster debate - Nature

Omicron is supercharging the COVID vaccine booster debate  Nature

How Ominous Is the Omicron Variant (B.1.1.529)? - American Society for Microbiology

How Ominous Is the Omicron Variant (B.1.1.529)?  American Society for Microbiology

T cell responses to SARS-CoV-2 spike cross-recognize Omicron - Nature

T cell responses to SARS-CoV-2 spike cross-recognize Omicron  Nature

Effects of Vaccination and Previous Infection on Omicron Infections in Children - The New England...

Effects of Vaccination and Previous Infection on Omicron Infections in Children  The New England Journal of Medicine

Modeling transmission of SARS-CoV-2 Omicron in China - Nature

Modeling transmission of SARS-CoV-2 Omicron in China  Nature

Omicron: increased transmissibility and decreased pathogenicity - Nature

Omicron: increased transmissibility and decreased pathogenicity  Nature

Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants - The New England Journ...

Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants  The New England Journal of Medicine

BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age - The New England...

BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age  The New England Journal of Medicine

People who catch Omicron are less likely to get Long Covid - Science | AAAS

People who catch Omicron are less likely to get Long Covid  Science | AAAS

Protection against Omicron from Vaccination and Previous Infection in a Prison System - The New E...

Protection against Omicron from Vaccination and Previous Infection in a Prison System  The New England Journal of Medicine

Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5 - Nature

Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5  Nature

If Omicron is less severe, why are COVID-19 deaths rising? - The World Economic Forum

If Omicron is less severe, why are COVID-19 deaths rising?  The World Economic Forum

Track Omicron’s spread with molecular data - Science | AAAS

Track Omicron’s spread with molecular data  Science | AAAS

Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2 - The Lancet

Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2  The Lancet

Scientists race to define Omicron threat, worried about ‘surge upon a surge’ - Harvard Gazette

Scientists race to define Omicron threat, worried about ‘surge upon a surge’  Harvard Gazette

Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa - Nature

Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa  Nature

​​3 Things to Know About Omicron and How to Stay Safe - AARP

​​3 Things to Know About Omicron and How to Stay Safe  AARP

Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar - The New England J...

Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar  The New England Journal of Medicine

What You Need to Know About XBB.1.5, the Latest Omicron Variant - Johns Hopkins Bloomberg School ...

What You Need to Know About XBB.1.5, the Latest Omicron Variant  Johns Hopkins Bloomberg School of Public Health

Durability of XBB.1.5 Vaccines against Omicron Subvariants - The New England Journal of Medicine

Durability of XBB.1.5 Vaccines against Omicron Subvariants  The New England Journal of Medicine

SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo - Nature

SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo  Nature

Omicron thwarts some of the world’s most-used COVID vaccines - Nature

Omicron thwarts some of the world’s most-used COVID vaccines  Nature

Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron - Nature

Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron  Nature

Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting - Nature

Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting  Nature

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants - Nature

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants  Nature

What Mayo experts know about the omicron variant - Mayo Clinic News Network

What Mayo experts know about the omicron variant  Mayo Clinic News Network

How effective are COVID-19 vaccines against omicron? - PBS

How effective are COVID-19 vaccines against omicron?  PBS

What doctors wish patients knew about the BA.2 Omicron subvariant - American Medical Association

What doctors wish patients knew about the BA.2 Omicron subvariant  American Medical Association

Resurgence of Omicron BA.2 in SARS-CoV-2 infection-naive Hong Kong - Nature

Resurgence of Omicron BA.2 in SARS-CoV-2 infection-naive Hong Kong  Nature